Skip to main content
SpringerLink
Log in

Improved Staging With Pretreatment Positron Emission Tomography/Computed Tomography in Low Rectal Cancer

  • Original Article
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

18F-Fluorodeoxyglucose (FDG)-positron emission tomography (PET) and computed tomography (CT) are widely accepted in the evaluation for metastatic or recurrent rectal cancer. Only spiral CT and transrectal ultrasonography (TRUS) are routinely used in the initial evaluation of primary rectal cancer. We wished to determine whether PET/CT could provide additional information in patients undergoing standard evaluation for primary rectal cancer.

Methods

Thirty-seven patients (mean age, 58 years; range, 26–90 years) with a previously untreated rectal cancer underwent TRUS or magnetic resonance imaging, spiral CT, and FDG-PET/CT. The tumor location (low, ≤6 cm; mid, 7–10 cm; or high, ≥10 cm) and carcinoembryonic antigen level were recorded. Discordant findings between spiral CT and FDG-PET/CT were confirmed by histological analysis or imaging follow-up.

Results

FDG-PET/CT identified discordant findings in 14 patients (38%), and this resulted in upstaging of 7 patients (50%) and downstaging of 3 patients (21%). Although node-positive disease on TRUS/magnetic resonance imaging was associated with discordant FDG-PET/CT findings, this was not statistically significant. Discordant PET/CT findings were significantly more common in patients with a low rectal cancer than in those with mid or high rectal cancer (13 vs. 1; P = .0027). The most common discordant finding was lymph node metastasis (n = 7; 50%). Histological confirmation of discordant FDG-PET/CT findings was performed in seven patients, and in no case did FDG-PET/CT prove to be inaccurate. Discordant PET/CT findings resulted in a deviation in the proposed treatment plan in 27% of patients (n = 10).

Conclusions

FDG-PET/CT frequently yields additional staging information in patients with low rectal cancer. Improved accuracy of pretreatment imaging with FDG-PET/CT will allow for more appropriate stage-specific therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Colon Cancer Facts and Figures, American Cancer Society Annual Report, Special Edition, 2005. Available: http://www.cancer.org/docroot/home/index.asp [accessed January 17, 2006]

  2. Schaffzin DM, Wong WD. Endorectal ultrasound in the preoperative evaluation of rectal cancer. Clinical Colorectal Cancer 2004;4:124–32

    PubMed  Google Scholar 

  3. Zerhouni EA, Rutter C, Hamilton SR, et al. CT and MRI imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology 1996;200:443–51

    CAS  PubMed  Google Scholar 

  4. Staib L, Schirmeister H, Reske SN, et al. Is 18F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg 2000;180:1–5

    Article  CAS  PubMed  Google Scholar 

  5. Ogunbiyi OA, Flanagan FL, Dehdashti F, et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computerized tomography. Ann Surg Oncol 1997;4:613–20

    Article  CAS  PubMed  Google Scholar 

  6. Even-Sapir E, Parag Y, Lerman H, et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 2004;232:815–22

    PubMed  Google Scholar 

  7. Guillem JG, Moore HG, Akhurst T, et al. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining long-term outcomes of rectal cancer. J Am Coll Surg 2004;199:1–7

    Article  PubMed  Google Scholar 

  8. Calvo FA, Domper M, Matute R, et al. 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 2004;58:528–35

    Article  PubMed  Google Scholar 

  9. Green F, Page K, Flemming I, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag, 2002:113–23

    Google Scholar 

  10. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365–71

    Article  CAS  PubMed  Google Scholar 

  11. Winawer SJ, Flehinger BJ, Schottenfeld D, Meller DG. Screening for colorectal cancer by fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993;85:1311–8

    CAS  PubMed  Google Scholar 

  12. Fisher B, Wlmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP Protocol R-01. J Natl Cancer Inst 1988;80:21–9

    CAS  PubMed  Google Scholar 

  13. Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000;92:388–96

    Article  CAS  PubMed  Google Scholar 

  14. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980–7

    Article  Google Scholar 

  15. Kapiteijn E, Marijnen C, Nagtegaal I, et al. Preoperative radiotherapy combined with total mesorectum excision for resectable rectal cancer. N Engl J Med 2001;345:638–46

    Article  CAS  PubMed  Google Scholar 

  16. Heriot AG, Hicks RJ, Drummond EG, et al. Does positron emission tomography change management in primary rectal cancer? A prospective assessment. Dis Colon Rectum 2004;47:451–8

    Article  PubMed  Google Scholar 

  17. Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002;45:200–6

    Article  PubMed  Google Scholar 

  18. Habr-Gama A, Perez RO, Nadalin W, et al. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg 2005;9:90–101

    PubMed  Google Scholar 

  19. Enker WE, Thaler HT, Cranor ML, et al. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995;181:335–46

    CAS  PubMed  Google Scholar 

  20. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707–11

    Article  CAS  PubMed  Google Scholar 

  21. Morita T, Murata A, Koyama M, et al. Current status of autonomic nerve-preserving surgery for mid and lower rectal cancer: Japanese experience with lateral node dissection. Dis Colon Rectum 2003;46:S78–87

    PubMed  Google Scholar 

  22. Hasdemir O, Col C, Yalcum E, et al. Local recurrence and survival rates after extended systematic lymph-node dissection for surgical treatment of rectal cancer. Hepatogastroenterology 2005;52:455–9

    PubMed  Google Scholar 

  23. Ciernik FI, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 2003;57:853–63

    Article  PubMed  Google Scholar 

  24. Mendenhall WM, Bland KI, Copeland EM, et al. Does preoperative radiation therapy enhance the probability of local control and survival in high-risk distal rectal cancer? Ann Surg 1992;215:696–705

    CAS  PubMed  Google Scholar 

  25. Camma C, Giunta M, Fiorica F, et al. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA 2000;284:1008–15

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Johns Hopkins Medical Institution, Blalock 656, 600 North Wolfe Street, Baltimore, Maryland, 21287

    Susan L. Gearhart MD, Michael Choti MD & Richard Schulick MD

  2. Department of Radiation Oncology, Johns Hopkins Medical Institution, Baltimore, Maryland, 21287

    Deborah Frassica MD

  3. Department of Radiology, Johns Hopkins Medical Institution, Baltimore, Maryland, 21287

    Ron Rosen MD & Richard Wahl MD

Authors
  1. Susan L. Gearhart MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deborah Frassica MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ron Rosen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael Choti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Richard Schulick MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Richard Wahl MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susan L. Gearhart MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gearhart, S.L., Frassica, D., Rosen, R. et al. Improved Staging With Pretreatment Positron Emission Tomography/Computed Tomography in Low Rectal Cancer. Ann Surg Oncol 13, 397–404 (2006). https://doi.org/10.1245/ASO.2006.04.042

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2006.04.042

Keywords

Search

Navigation